Biologic Therapies in Thyroid Eye Disease: A PRISMA-Based Systematic Review and Meta-Analysis of Clinical Outcomes, Safety Profiles and Impact on Surgical Management
Background: Biologic therapies have transformed Thyroid Eye Disease (TED) management, but their comparative efficacy, safety, durability and effects on subsequent rehabilitative surgery remain uncertain. Objective: To evaluate the efficacy and safety of teprotumumab, rituximab and tocilizumab across TED phenotypes and...